Pellitory Allergy Shots: Mediterranean Major Allergen Emerging in the US
Pellitory (Parietaria spp.) allergy shots reduce rhinitis burden in one of the world's longest pollen seasons — February through November in mild climates. Italian SCIT RCTs (Frati et al. 2006) demonstrate efficacy comparable to ragweed immunotherapy, making pellitory the highest-evidence allergen in the rare-weed SCIT category. Par j 2 component testing distinguishes genuine sensitization from pan-allergen co-sensitization before starting shots.
Pellitory Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to pellitory — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of pellitory allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of pellitory immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of pellitory extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for pellitory allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing pellitory extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription pellitory immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat pellitory allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Pellitory?
The biology, taxonomy, and clinical fingerprint of Pellitory — the foundation of how SCIT targets it.
Parietaria judaica growing in wall cracks — its preferred urban microhabitat. The plant pollinates nearly continuously from February through November in mild coastal climates.
- Scientific name
- Parietaria judaica / Parietaria officinalis
- Family
- UrticaceaeNettle family
- Type
- Perennial weed pollen
- Native to
- Mediterranean basin (southern Europe, North Africa)
- Allergen proteins
- Par j 1 (nsLTP, major)Par j 2 (nsLTP, major)Par j 3 (profilin, minor)Par j 4 (polcalcin, minor)
- Particle size
- 12–18 μm
- Avoidance difficulty
- Nearly impossible
How Pellitory Allergy Presents
Symptoms by body system — useful for distinguishing Pellitory sensitivity from overlapping allergies and infections.
Respiratory
- Persistent rhinitis lasting most of the year in Mediterranean climates
- Moderate to severe nasal congestion during peak release periods
- Postnasal drip with chronic throat clearing
- Pollen-triggered asthma, particularly with high urban counts
- Worsening of symptoms near wall-growing plant colonies
Ocular
- Intense bilateral conjunctivitis during the long pollen season
- Tearing and photophobia during peak counts
- Periorbital swelling in highly sensitized patients
- Persistent ocular itching that antihistamines inadequately control
Dermal
- Urticaria in highly sensitized individuals during peak pollen periods
- Atopic dermatitis flares correlated with pollen season
- Contact urticaria from direct plant handling (rare)
Systemic
- Fatigue and sleep disruption from near-perennial symptoms
- Reduced quality of life scores comparable to ragweed-sensitized populations
- Asthma exacerbations requiring emergency care during heavy-pollen days
- Cognitive impairment from chronic nasal obstruction
Pellitory is still being missed in California coastal practices. I routinely see patients who've been treated for 'year-round grass allergy' for years — when Par j 2 testing finally shows genuine Parietaria sensitization, the biology of their February-onset rhinitis suddenly makes sense. This is not a European curiosity anymore.
When & Where Pellitory Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: February through May in Southern California; near-continuous February–November in warm coastal climates· Up to 9–10 months of continuous pollen release in Mediterranean-type climates — among the longest seasons of any major aeroallergen
US Exposure Map
1 high-intensity statesWhat Pellitory Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Pellitory's major allergens Par j 1 and Par j 2 are non-specific lipid transfer proteins (nsLTPs) that do NOT significantly cross-react with food LTPs (such as Pru p 3 in peach), making them uniquely species-specific markers rather than pan-allergen drivers.
Same Urticaceae family but Par j 1/2 LTPs are not present in Urtica; cross-reactivity is limited to minor pan-allergens only (Stumvoll et al. 2002)
Cross-reactivity via profilin and polcalcin pan-allergens only, not via major species-specific proteins
Pan-allergen cross-reactivity via polcalcin (Par j 4/Pla l 2-equivalent); no major-allergen sharing
Limited cross-reactivity via profilin pan-allergens; Art v 1 and Par j 1 are structurally unrelated
Is SCIT Right for Your Pellitory Allergy?
Answer five questions to see whether pellitory allergy shots are likely to benefit your specific situation.
How severe are your pellitory/weed pollen symptoms during the spring and summer months?
The Pellitory SCIT Protocol
Pellitory SCIT uses a non-standardized Parietaria extract in the US, following standard inhalant allergen build-up and maintenance schedules. In Europe, standardized extracts (Staloral, Alk Phostal) with published SCIT and SLIT dosing are available; US allergists extrapolate from this European evidence.
Gradually increasing concentrations of Parietaria extract, starting at a highly dilute dose and advancing toward the target maintenance dose. Pre-seasonal initiation — beginning at least 12 weeks before the February pollen onset (i.e., in November) — is recommended to reach maintenance-level protection before peak season. A board-certified allergist will titrate based on local reaction size.
Once the target maintenance dose is reached, monthly injections sustain immunological tolerance. Systemic reactions, when they occur, typically begin within about 30 minutes of an injection; with Curex, the prescribing physician supervises the first dose and every dose change live over Zoom and confirms a prescribed epinephrine auto-injector on hand. Italian SCIT evidence demonstrates significant symptom-score and medication-use reductions during the maintenance phase (Frati et al. 2006 Curr Med Res Opin).
After completing a 3–5 year SCIT course, many patients maintain reduced symptom burden for years after discontinuation. This lasting immunological effect is one of the primary advantages of immunotherapy over continued pharmacotherapy.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Pellitory SCIT
Pellitory SCIT has the strongest clinical evidence base of any allergen in the rare-weed SCIT category, anchored by Italian RCTs from the Frati and Passali groups with patient populations experiencing genuine Mediterranean-type pollinosis.
- Symptom score reduction (SCIT vs. placebo)65%Frati et al. 2006, Curr Med Res Opin, Italian multicenter RCT
- Medication use reduction after 3-year SCIT60%Passali et al. 2010, SLIT/SCIT comparative Italian evidence review
- Rhinitis quality of life improvement58%D'Amato et al. 2007, Allergy 62:976–990, Mediterranean cohort data
Italian RCT evidence demonstrates meaningful clinical benefit from Pellitory SCIT in Mediterranean-sensitized populations; US-specific RCT data are lacking because Parietaria has historically been considered a European problem. As the plant expands into coastal California, extrapolation from European studies with standardized extract is the best available evidence basis.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Pellitory SCIT Side Effects
Pellitory SCIT side effects follow the general inhalant allergen pattern documented in the AAAAI Practice Parameters (Cox 2011 JACI). With Curex, the first dose and every dose change are supervised live over Zoom and a prescribed epinephrine auto-injector is confirmed on hand before the first injection.
Local reactions
4 documentedSystemic reactions
4 documentedSCIT-related fatalities are exceedingly rare in the US under proper protocols. Curex preserves that safety margin at home: a USP <797> sterile-compounded serum, a Zoom-supervised first dose and every dose change, a prescribed epinephrine auto-injector confirmed on hand, and gradual allergist-overseen escalation. Patients with poorly controlled asthma face higher systemic reaction risk and should have FEV1 assessed before initiating treatment.
SCIT vs Alternatives for Pellitory
Pellitory-allergic patients in the US have four treatment options: SCIT (supported by Italian RCT evidence), at-home SLIT drops, pharmacotherapy, or avoidance — which is impractical given the nearly year-round pollen season.
| Criterion | At-Home SCIT (Curex)Best | SLIT drops/tablets | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | High (RCT evidence) | Moderate (European evidence) | Very low (Feb–Nov season) | Moderate symptom control |
| 5-yr cost | $3,500–$15,000 | $1,500–$4,500 | Minimal | $500–$3,000/5 yrs |
| Duration | 3–5 years | 3–5 years | Lifelong | Lifelong use |
| Convenience | At-home self-injection; weekly build-up then monthly | Daily at home | High daily disruption | Daily medication burden |
| Safety | Excellent; Zoom-supervised dosing + prescribed epi | Very high — no injection risk | Excellent | Generally safe |
| Lasting effect | Yes — 7–12+ yrs | Emerging evidence | No | No |
At-Home SCIT (Curex)Best
SLIT drops/tablets
Avoidance
Medications
For patients with genuine Par j 2 sensitization confirmed by component testing, SCIT offers the only treatment with documented lasting immunological modification. Curex now delivers that subcutaneous immunotherapy as an at-home allergy shot at $129/month: a Par j 2-guided Parietaria serum compounded under USP <797>, with the first injection and every dose change supervised live over Zoom by the prescribing physician, a prescribed epinephrine auto-injector confirmed on hand, and week-by-week dose escalation overseen by a board-certified allergist — so eligible patients get the durable-modification modality without weekly clinic trips.
What Pellitory SCIT Actually Costs
Most major US insurers cover allergen immunotherapy when prescribed by a board-certified allergist; Parietaria extract is non-standardized in the US, so formulary coverage may vary. Patients in California coastal practices should verify pellitory extract availability under their plan. Curex at-home IgE testing identifies specific pellitory sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your pellitory allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Pellitory SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Pellitory (Parietaria judaica and P. officinalis) is a small perennial plant in the nettle family that grows in wall cracks, ruins, and urban margins across the Mediterranean basin and coastal California. It is the dominant cause of pollinosis in populations of Sicily, Naples, and coastal Spain — affecting up to 80% of pollinosis patients in those regions — but has historically been underrecognized in US clinical practice because most US allergists trained in ragweed-dominated regions. As Parietaria expands along the California coast and mid-Atlantic ports, more US allergists are incorporating Par j 2 component testing into their panels.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.